ZoomMed Inc. | Income Statement
Fiscal year is June-May. All values CAD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
7,806.40
1,742.20
-
-
-
Cost of Goods Sold (COGS) incl. D&A
1,326.70
1,399.20
117.60
16.50
51.10
Gross Income
6,479.70
343.00
117.60
16.50
51.10
SG&A Expense
2,726.50
2,394.40
1,631.40
1,653.30
1,708.60
EBIT
-
3,752.10
1,749.10
1,669.70
1,759.70
Unusual Expense
-
-
219.40
-
129.60
Non Operating Income/Expense
10.10
393.40
0.70
-
0.30
Interest Expense
362.30
526.30
9.20
15.10
114.60
Pretax Income
2,028.80
3,885.10
1,538.20
1,684.80
2,004.20
Income Tax
400.00
230.00
803.80
269.20
-
Equity in Affiliates
1,007.70
979.90
-
-
-
Consolidated Net Income
1,421.10
4,634.90
734.40
1,415.60
2,004.20
Net Income
1,421.10
4,634.90
734.40
1,415.60
2,004.20
Net Income After Extraordinaries
1,421.10
4,634.90
5,232.70
1,880.80
1,890.50
Net Income Available to Common
1,421.10
4,634.90
1,291.80
1,614.80
2,118.00
EPS (Basic)
0.01
0.04
0.03
0.01
0.02
Basic Shares Outstanding
130,474.70
132,454.90
135,591.30
135,591.30
135,591.30
EPS (Diluted)
0.01
0.03
0.03
0.01
0.02
Diluted Shares Outstanding
130,474.70
132,454.90
135,591.30
135,591.30
135,591.30
EBITDA
2,944.10
3,022.50
1,631.40
1,653.30
1,708.60
Other Operating Expense
1,352.10
1,700.70
-
-
-
About ZoomMed
View Profile
